Modulating T-cell response: Innovations in AAV8 gene therapy for retinal diseases

FHS
July 19, 2024
4:56 am

A new study shows that subretinal adeno-associated virus 8 (AAV8) injections cause proinflammatory T-cell immune response against the transgene product.

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit – Pharmaceutical Technology

There were still over 6,000 hospitalisations due to Covid-19 in the past week in the US. Unvaccinated adults are fives times more likely to die

July 11, 2023

Uni-Bio Science Group Announces 2023 Annual Results – Biotech Investments

EQS Newswire / 27/03/2024 / 23:00 UTC+8 Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology

March 28, 2024

Eye Drops for Presbyopia Win FDA Approval

The FDA approved pilocarpine hydrochloride ophthalmic solution (Qlosi) for adults with presbyopia, according to a statement from Orasis Pharmaceuticals. The approval allows for daily or

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.